The present study utilized four types of score (IPS, IPS-CTLA4, IPS-PD1-PDL1-PDL2 and IPS-CTLA4-PD1-PDL1-PDL2) to evaluate the potential of patients with glioma to be placed on ICIs. This evidence concerns the gene PDCD1LG2 and central nervous system cancer.